[Work capacity with long-term therapy of stomach and duodenal ulcers].
In consequence of newly developed ulcer drugs as H2-blocker and especially the ATPase-inhibitor omeprazole there is a rising chance to reduce drastically the relapse rate of gastroduodenal ulcers by long term administration of these drugs. By this, it is possible to improve significantly quality of life and ability for work for periods of years and to repress overt symptomatic chronic ulcer disease into a quiescent stage. Incapability for work and early retiring can be prohibited. Therefore the prognosis of chronic duodenal ulcer disease is significantly improved by long term treatment of ulcer disease using modern ulcer drugs.